Creating quite a stir, the New York Times this month published an article pointing out that what we do here in the addiction treatment industry is unproven, with the vast majority of treatment centers unable to back up their therapeutic approaches with data of any kind. And there is little, if any, in the way of of industry wide outcomes information, the collecof which - even if centers were to set aside their ceaseless, petty internecine squabbling - is made doubly difficult by the extreme fragmentation of the addiction treatment industry.

Already this has had a devastating impact on the industry, with commercial payors able to run roughshod, unilaterally reducing their contributiion to the nation’s treatment bill to less than 10 percent currentlyfrom 30 percent 25 years ago. And with state finances under increasing pressure, government payors will be looking to get more bang for their buck, and some states have already begun to link outcomes to funding. On the private side, Enterhealth, which we feature this month and is a company that was three years in the planning and development stage, uses evidence of success as a basis for inclusion of a therapeutic approach and science as a basis for experimenting with new ones.

Comments (0)

Subscribe to this comment's feed

Name

Email

Website

Title

Comment

smaller | bigger

Add Comment